Upon tumor engraftment mice were intraperitoneally injected with a first dose of 1x107 Non-Td or CoStAR-Td TIL, followed by additional 2 injections at 2- and 4- weeks post 1st infusion of 1x107 TIL, with IL-2 provided during the first week after TIL injection (Figure 6E). The gene discussed is IL2; the disease is neoplasm.